Tirzepatide
Tirzepatide peptide vials stocked in 10 mg strength across 3 ml format, supplied by Crowx Labs and Sixpex as single-vial packs. Each requires refrigerated storage and arrives as a compounded injectable, grouped here so buyers can compare the same concentration from different manufacturers without sorting through mixed-strength listings.
Try removing a filter to see more.
Tirzepatide injection vials from two labs sit in the grid below, each sold as a 10 mg peptide in 3 ml format with single-vial packing. Crowx Labs and Sixpex both supply this compound under the same strength and volume specification, so the choice comes down to lab preference, batch consistency, and how each maker handles cold-chain product finishing.
How the two makers compare
Both suppliers label their tirzepatide at identical concentrations and use the same milliliter count per vial. What separates them is manufacturing reputation, how thoroughly they document refrigeration handling during fulfillment, and the finish quality of stoppers and crimps. Buyers comparing these listings weigh lab track record against per-unit cost, knowing the peptide itself carries the same stated strength regardless of which name appears on the label.
Storage and handling standards
Every vial listed here requires refrigerated storage from the moment it leaves production until the buyer receives it. Tirzepatide degrades outside cold storage, so packaging insulation, shipping speed, and whether the lab includes temperature monitoring become deciding factors when choosing where to buy tirzepatide. A product that arrives warm is a product that cannot be trusted, no matter what the label states.
Differentiating tirzepatide from neighboring peptides
This section isolates one peptide rather than grouping multiple substances under a shared heading. Buyers browsing semaglutide for weight loss or retatrutide will find those compounds filed separately, each with its own strength range and lab selection. Tirzepatide dosages listed here all match at 10 mg, so filtering by strength is unnecessary—the grid compares makers, not concentrations.
What guides cover that product pages do not
- Reconstitution protocols and injection site rotation
- Dosing schedules and how they escalate over time
- Side effect profiles and how they compare across GLP-1 receptor agonists
- Brand-name equivalence to Mounjaro or Zepbound
- Mechanism of action and why the compound behaves as it does
- Conversion between micrograms and milligrams for tirzepatide brand comparisons